Understanding sex differences in the genetic basis of schizophrenia

A joint research study conducted by the UAB and the UB has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population.

Biotech and Donald Trump: A conversation about what comes next

This story was adapted from Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Adam: Hey Matt,

November 7, 2024

Eckert & Ziegler raises its forecast for the current financial year once again – Biotech Investments

Eckert & Ziegler SE / Key word(s): Change in Forecast Eckert & Ziegler raises its forecast for the current financial year once again 22-Nov-2024 /

November 23, 2024

Cellular Origins acquires Actia Platform IP to enhance automated cell therapy manufacturing

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced the acquisition of the

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.